This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaydos, C A Articles by Quinn, T C Search for Related Content PubMed PubMed Citation Articles by Gaydos, C A Articles by Quinn, T C

 Previous Article  |  Next Article 

J Clin Microbiol. 1990 July; 28(7): 1541-1544

Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.

Johns Hopkins University, Baltimore, Maryland 21205.

ABSTRACT

Detection of Chlamydia trachomatis infection was evaluated by culture and a new Syva enzyme immunoassay (EIA) in 1,012 patients at two Baltimore, Md., sexually transmitted disease clinics. The overall chlamydia prevalence determined by culture was 12%. For 506 fresh cervical and urethral specimens, the sensitivity of Syva EIA was 90% and its specificity was 94% compared with culture. Discordant Syva EIA results were further evaluated by staining the sediment in centrifuged culture transport media and Syva EIA transport tubes with a fluorescent monoclonal antibody to C. trachomatis to detect elementary bodies. Reanalysis of the data after use of this technique to resolve discordant results increased sensitivity and specificity to 92 and 96%, respectively. A subsample of 307 fresh cervical specimens was also tested in a three-way comparison using Abbott Chlamydiazyme, Syva EIA, and culture. In this sample, compared with culture, the sensitivity and specificity of Syva EIA were 87 and 95%, respectively, and for Chlamydiazyme they were 77 and 98%, respectively. Syva EIA is a 4-h, easy-to-perform enzyme-linked immunosorbent assay which has a high sensitivity with fresh genital specimens and offers an excellent alternative to culture.

This article has been cited by other articles:

• Martin, D. H., Nsuami, M., Schachter, J., Hook, E. W. III, Ferrero, D., Quinn, T. C., Gaydos, C. (2004). Use of Multiple Nucleic Acid Amplification Tests To Define the Infected-Patient "Gold Standard" in Clinical Trials of New Diagnostic Tests for Chlamydia trachomatis Infections. J. Clin. Microbiol. 42: 4749-4758 [Abstract] [Full Text]  
• Gaydos, C. A., Howell, M. R., Quinn, T. C., Gaydos, J. C., McKee, K. T. Jr. (1998). Use of Ligase Chain Reaction with Urine versus Cervical Culture for Detection of Chlamydia trachomatis in an Asymptomatic Military Population of Pregnant and Nonpregnant Females Attending Papanicolaou Smear Clinics. J. Clin. Microbiol. 36: 1300-1304 [Abstract] [Full Text]